Home Experience with External Quality Assessment of Drugs of Abuse Testing in the Lombardy Region in Italy
Article
Licensed
Unlicensed Requires Authentication

Experience with External Quality Assessment of Drugs of Abuse Testing in the Lombardy Region in Italy

  • Mario Cassani , Lucia Giuliani , Maurizio Amigoni , Antonietta Buratta and Alessandro Marocchi
Published/Copyright: June 1, 2005
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 40 Issue 2

Abstract

Following up previous experience with External Quality Assessment (EQA) and Proficiency Testing Programs (PTP) on drugs of abuse (DoA) testing in Italy and in other European countries, the government of the Lombardy Region, first among Italian regions, established in 1995 a compulsory EQA scheme for laboratories authorized to perform these tests. The purpose of the present work is the description of the program and the overall evaluation of the results obtained in the first three annual cycles (1995–1998).

During each annual cycle laboratories received 22 urine samples; some samples were collected from patients (“real samples”) and some were “spiked” urine samples. Both types of samples could contain the following substances/classes of substances: opiates, cocaine, cannabinoids, methadone, buprenorphine, benzodiazepines, barbiturates. Type A laboratories used an immunological screening method; they expressed the results as concentrations. Type B laboratories, authorized to perform screening methods followed by confirmatory techniques, searched for and identified single substances and provided an interpretation on possibly taken drugs.

During the study period the laboratories produced about 21 000 analytical results. Among them, falsenegative results were 0.9% of true positives, and falsepositive results were 0.7% of true negatives. Performance using the spiked samples was better than using real samples, and performance of type B laboratories better than that of type A.

The results obtained during the program are consistent with those of other quality control programs. This program, in addition, has provided information on the status of DoA testing in the Lombardy region's laboratories, in particular on their analytical performance, on the quality of interpretation of results and on a degree of improvement achieved during the program.

:
Published Online: 2005-06-01
Published in Print: 2002-03-01

Copyright © 2002 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. Recommendations for the Routine Use of Pancreatic Amylase Measurement instead of Total Amylase for the Diagnosis and Monitoring of Pancreatic Pathology
  2. Bovine Spongiform Encephalopathy: Are the Cows Mad or Full of Carbohydrates?
  3. Plasma Total Antioxidant Capacity in Hemodialyzed Patients and Its Relationships to other Biomarkers of Oxidative Stress and Lipid Peroxidation
  4. Effects of Propofol and Taurine on Intracellular Free Amino Acid Profiles and Immune Function Markers in Neutrophils In Vitro
  5. Genotyping of Hemochromatosis-Associated Mutations in the HFE Gene by PCR-RFLP and a Novel Revers Hybridization Method
  6. Comparison of Different CD71 Monoclonal Antibodies for Enrichment of Fetal Cells from Maternal Blood
  7. The Effects of Marathon Swimming on Serum Leptin and Plasma Neuropeptide Y Levels
  8. Renal Function Exerts only a Minor Influence on High Plasma Homocysteine Concentrations in Patients with Acute Coronary Syndromes
  9. Changes of Biochemical Bone Markers during the Menopausal Transition
  10. Blood Sampling for Biochemical Analysis from Central Venous Catheters: Minimizing the Volume of Discarded Blood
  11. Experience with External Quality Assessment of Drugs of Abuse Testing in the Lombardy Region in Italy
  12. Reference Intervals for Thyroid Hormones on the Architect Analyser
  13. Intermethod Variation in Serum Carcinoembryonic Antigen (CEA) Measurement. Fresh Serum Pools and Control Materials Compared
  14. Turn-Around Time for Chemical and Endocrinology Analyzers Studied Using Simulation
  15. A Two-Center Evaluation of the Blood Gas Immediate Response Mobile Analyzer (IRMA)
  16. Painting, Poetry and Optics: Johannes Vermeer
  17. The Practice of Clinical Chemistry in the European Union
  18. Meetings and Awards
Downloaded on 15.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2002.027/html
Scroll to top button